Clinical director


Colin Kerr
Published: Saturday, February 1, 2020
Heidelberg Engineering has appointed Christopher Mody as its Clinical Director.
In this new role, Dr Mody, an ophthalmic scientist with 30 years’ clinical ophthalmology experience in the public sector and seven years at Heidelberg Engineering UK, will be facilitating the exchange of scientific information between the global ophthalmic community and the company.
“Chris Mody is ideally suited to support our translational science program designed to deliver comprehensive, clinically relevant solutions to our customers. His knowledge will continue to strengthen our research alliances, while his passion for education will enhance the company’s role in advancing patient care.”, said Ali Tafreshi, Head of Product Management and Clinical Affairs at Heidelberg Engineering.
www.heidelbergengineering.com/int/company
Tags: industry
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.